Skip to content

menu

HomeAboutContactWhat's NewEducation Resources

Enter Search Terms

Cultivate

Legal insights from leading hemp and CBD lawyers

What's NewEducation ResourcesLitigation Tracker Sub-MenuMislabeling & Advertising ClaimsMedical & Health ClaimsShareholder LitigationDietary Supplement ClaimsLabor & Employment ClaimsIntellectual PropertyProduct Liability Claims

Uncategorized

Subscribe to Uncategorized

Welcome to Cultivate!

By DLA Piper on January 26, 2021

Posted in Uncategorized, What's New

Welcome to Cultivate, a DLA Piper blog focusing on critical legal issues affecting the nascent hemp and CBD industry.
Continue Reading Welcome to Cultivate!

Blog Managers

Photo of Christopher Gismondi

Christopher GismondiOf Counsel

Photo of Jae Kim

Jae KimAssociate, FDA Regulatory Group

Photo of Jarred Reiling

Jarred ReilingOf Counsel

Photo of Kelsey Tavares

Kelsey TavaresAssociate

Blog Authors Show/Hide

Kristin Beale
Stuart Brown
Christian Chessman
Maggie Craig
Stefanie Fogel
Melissa Gilmore
Christopher Gismondi
Jeffrey Hare
Jae Kim
Sharon Lindan Mayl
Wendy Michael
Jarred Reiling
Kelsey Tavares

Additional Topics

Additional Topics

Archives

Archives

Subscribe by Email

Your website url

Stay Connected

RSS Twitter LinkedIn Facebook YouTube Instagram Slideshare WeChat

Links & Resources

DLA Piper's Hemp and Hemp Regulated Products/CBD sector

Recent Posts

Two hemp-derived CBD bills are re-introduced despite FDA’s call for a different legislative fix
FDA seems willing to make room for a drug ingredient in a supplement, but what does that mean for CBD? NAC and the Drug Exclusion Clause of 201(ff)
A Green Light for Canna-Research? Medical Marijuana and CBD Research Bill on the Cusp
Federal Agencies’ Current Positions on Hemp-Derived CBD Products
Financial Services in the Cannabis Industry: A Compliance Guide

Legal NoticesPrivacy PolicyCookie Policydlapiper.com

RSS Twitter LinkedIn Facebook YouTube Instagram Slideshare WeChat

Copyright © 2023, DLA Piper. DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper’s structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.

Law blog design & platform by LexBlog